Modulim Announces Launch of Magnifi Clinical Workflow Software at Kidney Week 2022
Irvine, CA—Nov. 3, 2022 Scalable data management solution to drive clinical efficiency, improve workflow, and aide clinicians in patient management Modulim, a health technology company that delivers point-of-care microvascular and data insights to save limbs and improve lives, announces the launch of Magnifi at American Society of Nephrology’s Kidney Week 2022 in Orlando, FL, a software solution designed […]
Satellite Healthcare and Modulim Announce Strategic Partnership
Irvine, CA—July 12, 2022— Modulim, a health technology company that delivers point-of-care microvascular and data insights to save limbs and improve lives, announces a strategic partnership with Satellite Healthcare to standardize use of Modulim’s Limb Assessment, Management, and Preservation (LAMP) solution. Satellite is a 48 year old non-profit organization providing high quality dialysis services leading […]
Modulim Announces Intent to Drive Value-Based Care in Nephrology Market With Custom Limb Preservation Solution
Irvine, CA—July 6, 2022— Modulim, a health technology company that delivers point-of-care microvascular and data insights to save limbs and improve lives, announced today that it has launched its Limb Assessment, Management, & Preservation (LAMP) solution to enable accountable care organizations to achieve better outcomes for high-risk Chronic Kidney Disease (CKD) and End-Stage Renal Disease […]
Modulim Announces Appointment of Healthcare Technology Industry Veteran Carl St. Bernard to Board of Directors
Irvine, CA—May 10, 2022— Modulim, a health technology company that delivers point of care microvascular insight to save limbs and lives announces the appointment of Carl St. Bernard to its Board of Directors. Mr. St. Bernard has over 25 years of experience in medical technology leadership across a wide range of areas including vascular and medical imaging. […]
Modulim Announces New Vice President of Marketing
Irvine, CA—April 19, 2022— Irvine, CA—April 19, 2022—Modulim, a health technology company that delivers point of care microvascular insight to save limbs and lives, announces the appointment of Andre Grujovski as its new Vice President of Marketing. Learn about Andre and what’s next for Modulim here: https://www.prnewswire.com/news-releases/modulim-announces-new-vice-president-of-marketing-301528224.html About Modulim Modulim delivers transformative health technology solutions that […]
Modulim Featured in Article About Innovation on Main Page of UCI Website
Irvine, CA—July 2021 The UCI Beall Applied Innovation Center recognized Modulim CTO and Founder David Cuccia in a recent article on successful startups. Learn more about how Modulim started and how SFDI technology can be used to innovate healthcare. Link to the article: https://news.uci.edu/2021/07/23/incubating-innovation-2/ About Modulim Modulim is a privately held medical device company founded by […]
Modulated Imaging Technology Patented In Korea
Irvine, CA—June 28, 2021 Modulim, provider of optical imaging solutions that incorporate its patented spatial frequency domain imaging (SFDI) technology to transform healthcare and help people live healthier, longer lives, announced today that the Korean Intellectual Property Office has granted patent number 10-2251749 to Modulated Imaging Inc. (dba Modulim) for the invention of “efficient modulated […]
Modulim to Present at LSI Emerging MedTech Summit
Irvine, CA—May 12, 2021 Modulim’s CEO, Charlie Huiner, will be presenting at this year’s LSI 2021 Emerging Medtech Summit in Dana Point, CA May 11th-13th 2021. Modulim’s FDA-cleared Clarifi® Imaging solution is well positioned to help healthcare providers manage patients with diabetes, kidney disease, and peripheral arterial disease who are at risk for lower limb complications. SFDI […]
Case study shows how SFDI measures vascular steal in a post-surgical diabetic foot flap
Irvine, CA—April 1, 2021 Tissue flaps are commonly used in limb salvage to heal wounds and prevent amputations. Patients with advanced peripheral arterial disease (PAD), neurologic function, and diabetes mellitus (DM) often have difficulty with adequate oxygenation and perfusion to the periphery, making the success rates of the flap difficult. This observational case study published […]
Clinical publication reports that SFDI measures dermal microcirculatory changes prior to ulcer formation
Irvine, CA—March 8, 2021 In a recent case series published in the BMJ Open Diabetes Research & Care journal, a clinical research team lead by Dr. David Armstrong at USC measured the oxygenation and perfusion of neuropathic and neuroischemic ulcers with SFDI. The case series reported that unique signatures in the visual maps of oxygenation […]